CCN1 and psoriasis: To confirm these results in vivo, we further blocked CCN1 with a monoclonal antibody or a lentiviral vector expressing shRNA in IMQ-/IL-23-induced psoriasis-like mice and found impaired IL-1β expression following CCN1 silencing.